Tolfenamic acid and caffeine: a useful combination in migraine

Area of Science:

• Pharmacology
• Neurology
• Clinical Medicine

Background:

• Tolfenamic acid is a non-steroidal anti-inflammatory drug (NSAID) known for inhibiting prostaglandin synthesis.
• NSAIDs are frequently used for managing acute migraine attacks.
• The efficacy of adjunctive therapies to standard migraine treatments requires further investigation.

Purpose of the Study:

• To evaluate the effectiveness of caffeine, metoclopramide, and pyridoxine as adjuncts to tolfenamic acid in treating acute migraine attacks.
• To compare the efficacy of different tolfenamic acid combination therapies.

Main Methods:

• A randomized, crossover study involving ten patients with acute migraine attacks.
• Each patient received combinations of tolfenamic acid (200 mg) with either caffeine (100 mg), metoclopramide (10 mg), or pyridoxine (300 mg) twice.
• A total of 60 migraine attacks were treated and evaluated.

Main Results:

• The combination of tolfenamic acid and caffeine was the most effective treatment.
• This combination showed significant improvements in attack duration, intensity, patient working ability, and vigilance.
• Patients provided a higher overall evaluation for the tolfenamic acid-caffeine combination compared to the other tested adjuncts.
• Metoclopramide showed slightly better results than pyridoxine as an additive therapy.

Conclusions:

• Caffeine is a highly effective adjunct to tolfenamic acid for managing acute migraine attacks.
• The tolfenamic acid-caffeine combination offers a superior therapeutic option for migraine relief.
• Further research may explore optimal dosing and patient selection for this combination therapy.